EUVIMEDEUVIMED entdecken
Crossref

Bispecific Complement Engagers for Targeted Complement Activation

Dennis V Pedersen iD, Heidi Gytz, Mikael B L Winkler, Alessandra Zarantonello iD, Niklas Baumann iD, Annette G Hansen, Steffen Thiel iD, Gregers R Andersen iD, Thomas Valerius iD, Nick S Laursen iD

The Journal of Immunology · 2023

DOI: 10.4049/jimmunol.2200952 ↗

Kurz gefasst

Fachartikel in der Zeitschrift The Journal of Immunology, 2023. Verfasst von Dennis V Pedersen und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Molecular Biology and Genetics, Center for Structural Biology, Aarhus University, Aarhus C, Denmark. Hauptthemen laut MEDLINE: Complement C1q, Antineoplastic Agents. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 71 Literaturangaben. Gefördert von: Lundbeckfonden, Natur og Univers, Det Frie Forskningsråd, Novo Nordisk Fonden.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Activation of the complement system represents an important effector mechanism of endogenous and therapeutic Abs. However, efficient complement activation is restricted to a subset of Abs due to the requirement of multivalent interactions between the Ab Fc regions and the C1 complex. In the present study, we demonstrate that Fc-independent recruitment of C1 by modular bispecific single-domain Abs that simultaneously bind C1q and a surface Ag can potently activate the complement system. Using Ags from hematological and solid tumors, we show that these bispecific Abs are cytotoxic to human tumor cell lines that express the Ag and that the modular design allows a functional exchange of the targeting moiety. Direct comparison with clinically approved Abs demonstrates a superior ability of the bispecific Abs to induce complement-dependent cytotoxicity. The efficacy of the bispecific Abs to activate complement strongly depends on the epitope of the C1q binding Ab, demonstrating that the spatial orientation of the C1 complex upon Ag engagement is a critical factor for efficient complement activation. Collectively, our data provide insight into the mechanism of complement activation and provide a new platform for the development of immunotherapies.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Complement C1qAntineoplastic AgentsHumansComplement System ProteinsComplement ActivationCell Line, Tumor

Substanzen

Complement C1qComplement System ProteinsAntineoplastic Agents

Autor:innen und Institutionen

  • Department of Molecular Biology and Genetics, Center for Structural Biology, Aarhus University, Aarhus C, Denmark.
  • Division of Stem Cell Transplantation and Immunotherapy, Department of Medicine II, University Medical Center Schleswig-Holstein, Kiel, Germany.
  • Christian-Albrechts-University Kiel, Kiel, Germany.
  • Department of Biomedicine, Aarhus University, Aarhus C, Denmark.

ORCID-Profile: Dennis V Pedersen, Alessandra Zarantonello, Niklas Baumann, Steffen Thiel, Gregers R Andersen, Thomas Valerius, Nick S Laursen

Förderung

  • Lundbeckfonden
  • Natur og Univers, Det Frie Forskningsråd
  • Novo Nordisk Fonden

Zitieren

APA

Pedersen, D. V., Gytz, H., Winkler, M. B. L., Zarantonello, A., Baumann, N., Hansen, A. G., Thiel, S., Andersen, G. R., Valerius, T., & Laursen, N. S. (2023). Bispecific Complement Engagers for Targeted Complement Activation. The Journal of Immunology. https://doi.org/10.4049/jimmunol.2200952

Vancouver

Pedersen DV, Gytz H, Winkler MBL, Zarantonello A, Baumann N, Hansen AG, et al. Bispecific Complement Engagers for Targeted Complement Activation. The Journal of Immunology. 2023. doi:10.4049/jimmunol.2200952

BibTeX
@article{Pedersen2023,
  author = {Pedersen, Dennis V and Gytz, Heidi and Winkler, Mikael B L and Zarantonello, Alessandra and Baumann, Niklas and Hansen, Annette G and Thiel, Steffen and Andersen, Gregers R and Valerius, Thomas and Laursen, Nick S},
  title = {Bispecific Complement Engagers for Targeted Complement Activation},
  journal = {The Journal of Immunology},
  year = {2023},
  doi = {10.4049/jimmunol.2200952}
}
Kostenlos starten →